• Enesi Pharma secures innovate UK funding to manufacture ImplaVax biospectrumasia
    September 25, 2019
    Enesi Pharma ("Enesi"), the innovative pharmaceutical company developing unique injectable solid dose drug-device vaccine products, is delighted to announce that it has secured substantial funding from Innovate UK, the UK's innovation agency, under the Bi
PharmaSources Customer Service